22nd Century Group EBITDA per Share 2011-2026 | XXII

Annual EBITDA per Share 22nd Century Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
-60.2	-24 K	-4.66 K	-2.39	-0.17	-0.127	-0.167	-0.182	-0.122	-0.132	-0.167	-0.188	0.0448	-0.1	-0.135	-0.07	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.0448	-24 K	-1.79 K

Quarterly EBITDA per Share 22nd Century Group

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-4.91	-0.87	-11.4	-1.43	-	-766	-725	-183	-	-6.7	-13.5	-12.1	-	-1.08	-0.85	-0.05	-	-0.05	-0.04	-0.03	-0.04	-0.03	-0.03	-0.03	-0.04	-0.06	-0.04	-0.04	-0.05	-0.04	-0.05	-0.04	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.04	-0.04	-0.03	-0.03	-0.06	-0.09	-0.04	-0.03	-0.02	-	-0.02	-0.04	-0.04	-	-0.02	-0.05	-0.01	-	-0.03	-0.04	-0.02

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-0.01	-766	-32.6

EBITDA per Share of other stocks in the Biotechnology industry

Issuer	EBITDA per Share	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-0.71	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	-15.2	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-0.82	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	-2.35	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	-1.54	$ 1.64	-	$ 192 M	USA
I-Mab IMAB	0.08	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.75	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-0.23	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	-2.24	-	2.54 %	$ 160 B	France
BioNTech SE BNTX	-5.81	$ 92.25	-	$ 22.3 B	Germany
AstraZeneca PLC AZN	12.6	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.22	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-23.7	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-3.51	-	0.74 %	$ 768 M	Israel
Compugen Ltd. CGEN	0.34	$ 2.65	-	$ 248 M	Israel
Abcam plc ABCM	-0.04	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-0.03	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-0.03	-	-18.52 %	$ 27.3 M	Britain
Enlivex Therapeutics Ltd. ENLV	-0.32	$ 0.68	-	$ 31.1 M	Israel
Esperion Therapeutics ESPR	0.29	$ 3.12	-	$ 649 M	USA
Eton Pharmaceuticals ETON	0.12	$ 31.29	-	$ 842 M	USA
Affimed N.V. AFMD	-0.54	-	-34.95 %	$ 21.5 M	Germany
Forte Biosciences FBRX	-5.45	$ 21.94	1.62 %	$ 284 M	USA
Институт стволовых клеток человека ISKJ	-2.69	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-2.84	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-1.81	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-1.29	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	-2.06	-	-	$ 344 M	USA
IMV IMV	-0.28	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-4.25	-	-	$ 3.67 B	USA
Akouos AKUS	-2.45	-	0.23 %	$ 488 M	USA
Grifols, S.A. GRFS	1.75	$ 8.01	-	$ 5.44 B	Spain
Ayala Pharmaceuticals AYLA	-2.42	-	-	$ 7.46 M	Israel
Hutchison China MediTech Limited HCM	-0.03	$ 11.75	-	$ 10.1 B	China
Cyclacel Pharmaceuticals CYCCP	-3.85	-	-4.36 %	$ 27 M	USA
Heron Therapeutics HRTX	-0.06	$ 0.88	-	$ 147 M	USA
Freeline Therapeutics Holdings plc FRLN	-1.63	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-1.67	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	-0.4	$ 14.89	-	$ 214 M	USA
Advaxis ADXS	-5.96	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-3.37	-	5.93 %	$ 314 M	Canada
InflaRx N.V. IFRX	-0.82	$ 2.74	-	$ 184 M	Germany
Aeglea BioTherapeutics AGLE	-6.7	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-2.22	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-0.36	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-3.89	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-6.03	$ 3.44	-	$ 5.66 M	Israel
Aptose Biosciences APTO	0.01	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-0.92	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-6.41	-	-0.23 %	$ 916 M	USA